Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease
· inc., ethyreal bio
Source Summary
– ETHY-001 targets the causal pathogenic mechanism underlying both conditions –
Advertisement